Man Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $388M | Buy |
422,016
+60,956
| +17% | +$61.8M | 0.7% | 11 |
|
|
2025
Q4 | $388M | Buy |
361,060
+28,319
| +9% | +$27.1M | 0.66% | 17 |
|
|
2025
Q3 | $254M | Buy |
332,741
+17,166
| +5% | +$12.8M | 0.44% | 33 |
|
|
2025
Q2 | $246M | Buy |
315,575
+36,102
| +13% | +$28.1M | 0.47% | 28 |
|
|
2025
Q1 | $231M | Sell |
279,473
-6,413
| -2% | -$5.34M | 0.59% | 15 |
|
|
2024
Q4 | $221M | Buy |
285,886
+12,361
| +5% | +$10.2M | 0.58% | 21 |
|
|
2024
Q3 | $242M | Sell |
273,525
-73,748
| -21% | -$66.3M | 0.63% | 9 |
|
|
2024
Q2 | $314M | Buy |
347,273
+33,091
| +11% | +$26.5M | 0.79% | 9 |
|
|
2024
Q1 | $244M | Buy |
314,182
+129,561
| +70% | +$92.2M | 0.62% | 18 |
|
|
2023
Q4 | $108M | Buy |
+184,621
| New | +$108M | 0.3% | 61 |
|
|
2023
Q3 | – | Sell |
-84,622
| Closed | -$43.6M | – | 177 |
|
|
2023
Q2 | $39.7M | Buy |
+84,622
| New | +$35.5M | 0.12% | 192 |
|
|
2023
Q1 | – | Sell |
-108,231
| Closed | -$36.5M | – | 157 |
|
|
2022
Q4 | $39.6M | Buy |
108,231
+45,239
| +72% | +$16M | 0.14% | 175 |
|
|
2022
Q3 | $20.4M | Buy |
+62,992
| New | +$20M | 0.09% | 254 |
|
|
2022
Q2 | – | Sell |
-85,887
| Closed | -$25.8M | – | 175 |
|
|
2022
Q1 | $24.6M | Buy |
85,887
+548
| +0.6% | +$141K | 0.09% | 261 |
|
|
2021
Q4 | $23.6M | Sell |
85,339
-67,445
| -44% | -$17.1M | 0.08% | 318 |
|
|
2021
Q3 | $35.3M | Buy |
152,784
+10,935
| +8% | +$2.7M | 0.12% | 179 |
|
|
2021
Q2 | $32.6M | Sell |
141,849
-121,293
| -46% | -$24.4M | 0.11% | 188 |
|
|
2021
Q1 | $49.2M | Buy |
263,142
+71,313
| +37% | +$13.9M | 0.22% | 104 |
|
|
2020
Q4 | $32.4M | Sell |
191,829
-32,771
| -15% | -$4.89M | 0.14% | 141 |
|
|
2020
Q3 | $33.2M | Buy |
224,600
+63,217
| +39% | +$9.78M | 0.13% | 160 |
|
|
2020
Q2 | $26.5M | Sell |
161,383
-9,363
| -5% | -$1.44M | 0.13% | 140 |
|
|
2020
Q1 | $23.7M | Buy |
170,746
+18,050
| +12% | +$2.48M | 0.15% | 136 |
|
|
2019
Q4 | $20.1M | Buy |
152,696
+33,581
| +28% | +$3.89M | 0.07% | 351 |
|
|
2019
Q3 | $13.3M | Sell |
119,115
-11,844
| -9% | -$1.32M | 0.05% | 445 |
|
|
2019
Q2 | $14.5M | Sell |
130,959
-137,859
| -51% | -$16.2M | 0.05% | 467 |
|
|
2019
Q1 | $34.9M | Sell |
268,818
-105,865
| -28% | -$12.9M | 0.13% | 176 |
|
|
2018
Q4 | $43.4M | Sell |
374,683
-143,361
| -28% | -$16M | 0.19% | 112 |
|
|
2018
Q3 | $55.6M | Buy |
518,044
+207,719
| +67% | +$20.8M | 0.2% | 92 |
|
|
2018
Q2 | $26.5M | Buy |
310,325
+61,727
| +25% | +$5.07M | 0.11% | 190 |
|
|
2018
Q1 | $19.2M | Buy |
+248,598
| New | +$20M | 0.09% | 241 |
|
Other funds holding LLY
VCM
VPM
Man Group's LLY Position: Q1 2026 in Review
Man Group increased its Eli Lilly (LLY) stake by 17% in Q1 2026, buying an estimated $61.8M and bringing the position to 422,016 shares worth $388M. The position accounts for 0.7% of the portfolio, ranked #11.
Man Group first reported a position in LLY in Q1 2018 and has held it in 30 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Man Group held 422,016 shares of Eli Lilly worth $388M as of Q1 2026.
- Man Group bought 60,956 Eli Lilly shares in Q1 2026, an estimated $61.8M.
- Eli Lilly made up 0.7% of Man Group's portfolio in Q1 2026, its #11 holding.
- Man Group first reported a position in Eli Lilly in Q1 2018 and has held it in 30 quarters since.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.